- Home
- CLSD vs RPTX Comparison
CLSD vs RPTX Comparison
Compare CLSD & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- RPTX
- Stock Information
- Founded
- CLSD 2011
- RPTX 2016
- Country
- CLSD United States
- RPTX Canada
- Employees
- CLSD N/A
- RPTX N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLSD Health Care
- RPTX Health Care
- Exchange
- CLSD Nasdaq
- RPTX Nasdaq
- Market Cap
- CLSD 68.4M
- RPTX 63.9M
- IPO Year
- CLSD 2016
- RPTX 2020
- Fundamental
- Price
- CLSD $0.46
- RPTX $1.57
- Analyst Decision
- CLSD Hold
- RPTX Strong Buy
- Analyst Count
- CLSD 4
- RPTX 3
- Target Price
- CLSD $4.33
- RPTX $4.50
- AVG Volume (30 Days)
- CLSD 12.7M
- RPTX 717.8K
- Earning Date
- CLSD 08-11-2025
- RPTX 08-05-2025
- Dividend Yield
- CLSD N/A
- RPTX N/A
- EPS Growth
- CLSD N/A
- RPTX N/A
- EPS
- CLSD N/A
- RPTX N/A
- Revenue
- CLSD $3,764,000.00
- RPTX $1,073,000.00
- Revenue This Year
- CLSD $143.33
- RPTX N/A
- Revenue Next Year
- CLSD N/A
- RPTX N/A
- P/E Ratio
- CLSD N/A
- RPTX N/A
- Revenue Growth
- CLSD N/A
- RPTX N/A
- 52 Week Low
- CLSD $0.29
- RPTX $0.89
- 52 Week High
- CLSD $1.65
- RPTX $4.22
- Technical
- Relative Strength Index (RSI)
- CLSD 34.58
- RPTX 57.98
- Support Level
- CLSD $0.29
- RPTX $1.37
- Resistance Level
- CLSD $0.62
- RPTX $1.62
- Average True Range (ATR)
- CLSD 0.11
- RPTX 0.07
- MACD
- CLSD -0.02
- RPTX 0.00
- Stochastic Oscillator
- CLSD 25.16
- RPTX 62.90
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.